Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 14;11(11):2765.
doi: 10.3390/microorganisms11112765.

Changing Strategies for the Detection of Bacteria in Platelet Components in Ireland: From Primary and Secondary Culture (2010-2020) to Large Volume Delayed Sampling (2020-2023)

Affiliations

Changing Strategies for the Detection of Bacteria in Platelet Components in Ireland: From Primary and Secondary Culture (2010-2020) to Large Volume Delayed Sampling (2020-2023)

Niamh O'Flaherty et al. Microorganisms. .

Abstract

Bacterial contamination of platelet components (PC) poses the greatest microbial risk to recipients, as bacteria can multiply over the course of PC storage at room temperature. Between 2010 and 2020, the Irish Blood Transfusion Service (IBTS) screened over 170,000 buffy coat-derived pooled (BCDP) and single-donor apheresis platelets (SDAPs) with the BACT/ALERT 3D microbial detection system (Biomerieux, L'Etoile, France), using a two-step screening protocol which incorporated primary and secondary cultures. Although the protocol was successful in averting septic transfusion reactions (STRs), testing large sample volumes at later time points was reported to improve detection of bacterial contamination. A modified large-volume delayed sampling (LVDS)-type protocol was adopted in 2020, which in the case of SDAP was applied to collections rather than individual splits (2020-2023, 44,642 PC screened). Rates of bacterial contamination for BCDP were 0.125% on Day-2, 0.043% on Day-4 vs. 0.191% in the post-LVDS period. SDAP contamination rates in the pre-LVDS period were 0.065% on Day-1, 0.017% on Day-4 vs. 0.072% in the post-LVDS period. Confirmed STRs were absent, and the interdiction rate for possibly contaminated SDAP was over 70%. In the post-LVDS period, BCDPs had a higher total positivity rate than SDAPs, 0.191% (1:525) versus 0.072% (1:1385), respectively, (chi-squared 12.124, 1 df, p = 0.0005). The majority of organisms detected were skin-flora-type, low pathogenicity organisms, including coagulase-negative staphylococci and Cutibacterium acnes, with little change in the frequency of clinically significant organisms identified over time. Both protocols prevented the issue of potentially harmful components contaminated (rarely) with a range of pathogenic bacteria, including Escherichia coli, Serratia marcesens, Staphylococcus aureus, and streptococci. Culture positivity of outdates post-LVDS whereby 100% of expired platelets are retested provides a residual risk estimate of 0.06% (95% CI 0.016-0.150). However, bacterial contamination rates in expired platelets did not demonstrate a statistically significant difference between the pre-LVDS 0.100% (CI 0.033-0.234) and post-LVDS 0.059% (0.016-0.150) periods (chi-squared = 0.651, 1 df, p = 0.42).

Keywords: bacteria; bacterial culture; contamination rates; platelet components (PCs); risk; safety; transfusion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Frequency of organisms detected as a percentage of all confirmed or indeterminate investigations for each platelet type pre-LVDS.
Figure 2
Figure 2
Frequency of confirmed and indeterminate positive cultures per bottle type.
Figure 3
Figure 3
Combined positivity rates for SDAP and BCDP platelets over time.

References

    1. James J.D. Bacterial Contamination of Preserved Blood. Vox Sang. 1959;4:177–185. doi: 10.1111/j.1423-0410.1959.tb05127.x. - DOI - PubMed
    1. Bonnel P.H. Bacterial Contamination of Preserved Blood and Derivatives. Vox Sang. 1961;6:60–67. doi: 10.1111/j.1423-0410.1961.tb03136.x. - DOI
    1. Robillard P., Delage G., Itaj N.K., Goldman M. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection. Transfusion. 2011;51:1405–1411. doi: 10.1111/j.1537-2995.2010.03001.x. - DOI - PubMed
    1. Kelton J.G., Blajchman M.A. Platelet transfusions. Can. Med. Assoc. J. 1979;121:1353–1358. - PMC - PubMed
    1. Wagner S.J., Friedman L.I., Dodd R.Y. Transfusion-associated bacterial sepsis. Clin. Microbiol. Rev. 1994;7:290–302. doi: 10.1128/CMR.7.3.290. - DOI - PMC - PubMed

LinkOut - more resources